Comparison of adjuvant capecitabine plus oxaliplatin (CAPOX) versus S-1 after gastrectomy: a population-based cohort study using a nationwide claims database

Although both capecitabine plus oxaliplatin (CAPOX) and S-1 are accepted as adjuvant chemotherapy following gastrectomy for gastric cancer, the better option between the two is still controversial. We conducted a retrospective nationwide cohort study using data from the National Health Insurance Ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeng, Chi Hoon, Kim, Hoseob, Kim, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567838/
https://www.ncbi.nlm.nih.gov/pubmed/37821636
http://dx.doi.org/10.1038/s41598-023-44117-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567838/
https://www.ncbi.nlm.nih.gov/pubmed/37821636
http://dx.doi.org/10.1038/s41598-023-44117-3

Ejemplares similares